2019
DOI: 10.1111/1751-2980.12699
|View full text |Cite
|
Sign up to set email alerts
|

Chinese expert consensus on perioperative medications for endoscopic retrograde cholangiopancreatography (ERCP)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 99 publications
(172 reference statements)
0
5
0
Order By: Relevance
“…Somatostatin is a promising pharmacological agent because of its positive biological impacts, such as exocrine pancreatic secretion inhibition, reduction of the sphincter of Oddi contractions, modulation of the cytokine cascade, and protection against possible pancreatic acinar 14 . The efficiency of somatostatin against PEP is recognized by scholars globally and is written into the guideline 15 …”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Somatostatin is a promising pharmacological agent because of its positive biological impacts, such as exocrine pancreatic secretion inhibition, reduction of the sphincter of Oddi contractions, modulation of the cytokine cascade, and protection against possible pancreatic acinar 14 . The efficiency of somatostatin against PEP is recognized by scholars globally and is written into the guideline 15 …”
Section: Discussionmentioning
confidence: 99%
“…14 The efficiency of somatostatin against PEP is recognized by scholars globally and is written into the guideline. 15 This investigation adopted a factorial design and grouped patients into placebo, indomethacin, somatostatin, and indomethacin + somatostatin groups. The data revealed that VAS levels of IL-6, TNF-α, and IL-8 substantially increased in all 4 groups, sequentially from 6 to 24 h post operation in comparison with pretreatment, suggesting that ERCP-induced inflammatory reaction can be alleviated by somatostatin and indomethacin.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…[ 112 ] Rectal NSAID is the mainstay of PEP prophylaxis and its use is advocated by a number of societies. [ 49 91 113 114 ] The issue of whether the addition of PD stenting confers any advantage is under investigation in the ongoing stent versus indomethacin trial. [ 115 ]…”
Section: Pancreatitis Prophylaxis Post-ercp Pancreatitismentioning
confidence: 99%
“…In 2013, a network meta-analysis identified topical epinephrine as the most efficacious prophylaxis for PEP [8]. However, epinephrine was not retained in any of the four subsequent guidelines from large Endoscopy Societies on this topic [5,[9][10][11]. That is because the network meta-analysis included only two randomized controlled trials (RCTs); furthermore, these excluded (!)…”
Section: Target Population Timingmentioning
confidence: 99%